Urinary Incontinence: Diagnostic Strategies and Conservative Management with Dr. Scott Farrell
Urinary incontinence is a condition resulting in the involuntary release of urine and affects more than 3.3 million Canadians (nearly 10% of the population).
Clinical studies demonstrate that patients who identify as having urinary incontinence report significant need to modify day-to-day activities because of urine leakage. Additionally, people suffering with incontinence experience emotions such as embarrassment, discouragement and frustration.
Physiotherapists are uniquely positioned within the healthcare continuum of care to help identify, manage and support patients through conservative management approaches for both stress and urge urinary incontinence.
This online course will help physiotherapists differentiate between urge incontinence and stress incontinence, determine when pelvic floor physiotherapy may be indicated and understand which patients may benefit from pessaries as an adjunct to physiotherapy management.
- Discuss clinical presentation & pathophysiology of various types of urinary incontinence (UI) in women.
- Describe a practical approach to diagnosis.
- Review the various treatment options for urinary incontinence (UI) in women, including pelvic floor physiotherapy, lifestyle modifications, behavioural therapies, use of a pessary and surgery.
- Understand the benefits, risks and contraindications of use of the uresta® pessary to manage stress incontinence.
Dr. Scott Farrell, BA BEd MD FRCSC
Dr. Farrell has played a leading role in the care of women with incontinence in Canada and internationally, publishing over fifty peer-reviewed journal articles. He served as chair of the Urogyneacology Committee of the Society of Obstetrics and Gynaecology (SOGC) that published a number of medical practice guidelines. His relationship with the SOGC culminated with service as its President in 2009.
Dr. Farrell has had a career-long interest in conservative, non-surgical treatment of urinary incontinence. This interest prompted the design of the Uresta continence device and the conduct of clinical trials to confirm its efficacy.